View details of this raise on Seedstage

San Diego, CA

Developing AI-integrated smart glasses and contact lenses to restore functional sight for the visually impaired.

• Patented innovation: 75 filed patents covering advanced smart glasses and contact lens technology.
• Clinical validation: Demonstrated functional vision restoration in independent testing.
• AI-ready platform: Designed for integration with intelligent assistants and real-time visual support.
• Significant funding: $20M raised with backing from major industry partners.
• Broad market potential: Targeting medical and commercial applications across multiple industries.

Innovega is developing patented smart glasses and contact lenses aimed at restoring functional sight for people with moderate to severe visual impairments, including those who are legally blind. The company’s technology combines lightweight eyewear with advanced optics, offering personalized vision enhancement for everyday activities. For those with profound vision loss, a contact lens and glasses combination can provide functional vision comparable to 20/20, based on early clinical testing. Designed to integrate with AI tools, these devices aim to deliver real-time assistance and accessibility features that support independence and daily living.

Backed by significant intellectual property, funding from industry leaders, and strategic development contracts, Innovega is transitioning from clinical validation to commercialization. The company plans to launch products first for the vision-impaired market, then expand into additional sectors such as defense, sports, and enterprise. Funds raised will be used to advance manufacturing, scale production, and support market entry. By addressing both medical needs and broader applications, the company aims to position its platform as a foundation for next-generation wearable vision solutions.

Company Info

Innovega designs patented smart glasses and contact lenses to restore functional vision for people with moderate to severe impairments and integrate with AI-powered tools.

Innovega develops patented smart glasses and contact lenses designed to restore functional vision for people with moderate to severe visual impairments, including those who are legally blind. The company offers two main products: a glasses-only system for moderate impairment and a combination of smart glasses with nanotech contact lenses for severe impairment, enabling up to 20/20 functional vision in clinical testing. These devices are lightweight, discreet, and customizable to individual vision needs, with features such as high-zoom displays, wide fields of view, and the ability to integrate with prescription lenses. Innovega’s technology targets conditions such as macular degeneration, diabetic retinopathy, Stargardt disease, glaucoma, and ocular albinism, aiming to improve reading ability, facial recognition, and navigation for users.

The platform is designed for real-world use and is built to integrate with AI-powered tools for object recognition, real-time guidance, and personalized assistance. Innovega holds over 75 patents, has raised $20 million in funding, and secured $6 million in non-dilutive contracts. Beyond the vision impairment market, the technology has potential applications in defense, sports, entertainment, and enterprise sectors. The global market for vision-enhancing wearable technology is projected to exceed $150 billion within the next decade, with smart glasses alone expected to surpass $50 billion by 2030.